Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
3.260
-0.010 (-0.31%)
At close: Sep 17, 2025, 4:00 PM EDT
3.300
+0.040 (1.23%)
After-hours: Sep 17, 2025, 7:59 PM EDT
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $1.12 billion as of September 17, 2025. Its market cap has increased by 39.90% in one year.
Market Cap
1.12B
Enterprise Value
565.85M
1-Year Change
39.90%
Ranking
Category
Stock Price
$3.26
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $1.12B, an increase of 539.51%. That is a compound annual growth rate of 44.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 1.12B | 25.02% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | 210.45M | 20.62% |
| Aug 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |